69 related articles for article (PubMed ID: 7513142)
1. Development of tumorigenicity and rearrangement of chromosome 1 correlates with down-regulation of cell-surface glycoproteins in human mammary carcinoma cell line.
Imam SA; Pathak S; Brown N; Yilmaz A; Taylor CR
Anticancer Res; 1994; 14(1A):229-36. PubMed ID: 7513142
[TBL] [Abstract][Full Text] [Related]
2. A sialoglycoprotein (LEA.135) associated with favourable prognosis of patients with lymph node-negative primary breast carcinoma.
Imam SA; Chaiwun B; Wang MJ; Morris MM; Groshen SG; Neville AM; Torloni H; Cote RJ; Taylor CR
Anticancer Res; 1996; 16(5B):3043-8. PubMed ID: 8920764
[TBL] [Abstract][Full Text] [Related]
3. Identification of a cell-surface glycoprotein associated with normal mammary and extramammary epithelial cells.
Imam SA; Stampfer MR; Yilmaz A; Taylor CR
Br J Cancer; 1994 Mar; 69(3):439-44. PubMed ID: 8123470
[TBL] [Abstract][Full Text] [Related]
4. Identification of a cell-surface antigen (LEA.135) associated with favorable prognosis in human breast cancer.
Imam SA; Esteban EF; Chen RS; Cardiff RD; Taylor CR
Cancer Res; 1993 Jul; 53(14):3233-6. PubMed ID: 7686814
[TBL] [Abstract][Full Text] [Related]
5. Generation of a murine monoclonal antibody to normal mammary epithelium using mice rendered immune-tolerant to malignant mammary epithelium.
Imam SA; Esteban EF; Young LL; Taylor CR
J Histochem Cytochem; 1994 May; 42(5):585-91. PubMed ID: 7512585
[TBL] [Abstract][Full Text] [Related]
6. Human models of breast cancer.
Taylor-Papadimitriou J; Berdichevsky F; D'Souza B; Burchell J
Cancer Surv; 1993; 16():59-78. PubMed ID: 8348539
[TBL] [Abstract][Full Text] [Related]
7. Luminal epithelial antigen (LEA.135) expression correlates with tumor progression for transitional carcinoma of the bladder.
Jones HL; Delahunt B; Bethwaite PB; Thornton A
Anticancer Res; 1997; 17(1B):685-7. PubMed ID: 9066602
[TBL] [Abstract][Full Text] [Related]
8. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
10. Systematic determination of telomerase activity and telomerase length during the progression of human breast cancer in cell culture models.
Imam SA; Kim MS; Anker L; Datar RH; Law RE; Taylor CR
Anticancer Res; 1997; 17(6D):4435-41. PubMed ID: 9494546
[TBL] [Abstract][Full Text] [Related]
11. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
12. Expression and regulation by serum of multiple FGF1 mRNA in normal transformed, and malignant human mammary epithelial cells.
Renaud F; El Yazidi I; Boilly-Marer Y; Courtois Y; Laurent M
Biochem Biophys Res Commun; 1996 Feb; 219(3):679-85. PubMed ID: 8645241
[TBL] [Abstract][Full Text] [Related]
13. LEA.135 expression: identifies low-risk patients with breast ductal carcinoma in situ.
Baltayan A; Naritoku WY; Chaiwun B; Tsao-Wei DD; Groshen S; Hern RA; Gusterson BA; Taylor CR; Imam SA
Anticancer Res; 2002; 22(5):2933-7. PubMed ID: 12530020
[TBL] [Abstract][Full Text] [Related]
14. Variability in surface antigen expression of human breast epithelial cells cultured from normal breast, normal tissue peripheral to breast carcinomas, and breast carcinomas.
Ceriani RL; Peterson JA; Blank EW
Cancer Res; 1984 Jul; 44(7):3033-9. PubMed ID: 6144385
[TBL] [Abstract][Full Text] [Related]
15. Luminal epithelial antigen (LEA.135) expression in adenocarcinoma of the colon.
Miles SE; Kenwright DN; Gaskell DJ; Christie RM; Thornton A; Delahunt B
Anticancer Res; 1999; 19(1A):597-600. PubMed ID: 10226604
[TBL] [Abstract][Full Text] [Related]
16. LEA.135 expression: its comparison with other prognostic biomarkers for patients with primary breast carcinoma.
Liu D; Baltayan A; Naritoku WY; Barr NJ; Young LL; Chaiwun B; Tsao-Wei DD; Groshen SL; Taylor CR; Torloni H; Neville AM; Cote RJ; Imam SA
Anticancer Res; 2000; 20(3A):1451-61. PubMed ID: 10928056
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
[TBL] [Abstract][Full Text] [Related]
18. KAI1 protein is down-regulated during the progression of human breast cancer.
Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M
Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
Liu L; Gudas LJ
J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
[TBL] [Abstract][Full Text] [Related]
20. Expression of carcinoembryonic antigen and nonspecific cross-reacting 50-kDa antigen in human normal and cancerous colon mucosa: comparative ultrastructural study with monoclonal antibodies.
Baranov V; Yeung MM; Hammarström S
Cancer Res; 1994 Jun; 54(12):3305-14. PubMed ID: 8205554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
